Coronavirus epidemiology and demographics: Difference between revisions
Line 15: | Line 15: | ||
* From June 2012 to April 2018, [[Middle East respiratory syndrome coronavirus infection causes|MERS-CoV infection]] was [[Prevalence|prevalent]] in 2206 people globally. | * From June 2012 to April 2018, [[Middle East respiratory syndrome coronavirus infection causes|MERS-CoV infection]] was [[Prevalence|prevalent]] in 2206 people globally. | ||
*To date, 96, | *To date, 96,888 confirmed cases of COVID-19 have emerged. | ||
*For details on the real-time [[prevalence]] and spread of COVID-19, click [https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 here].<ref>{{Cite web|url=https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6|title=|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | *For details on the real-time [[prevalence]] and spread of COVID-19, click [https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 here].<ref>{{Cite web|url=https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6|title=|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | ||
Revision as of 16:48, 5 March 2020
Coronavirus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Coronavirus epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Coronavirus epidemiology and demographics |
Risk calculators and risk factors for Coronavirus epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2], Syed Hassan A. Kazmi BSc, MD [3]
Overview
Due to the lack of data, the exact incidence rate of coronavirus infections can not be approximated. With 8,098 confirmed cases, the case fatality-rate of SARS was 9.6%. With 2465 laboratory-confirmed cases, the case fatality-rate of MERS was 34.4%. The case fatality-rate of 2019-nCoV in the first 99 patients at a Wuhan hospital (the epicenter of the outbreak) has been found to be 11%.
Epidemiology and Demographics
Incidence
- Due to the lack of data, the exact incidence rate of coronavirus infections can not be approximated.
Prevalance
- From June 2012 to April 2018, MERS-CoV infection was prevalent in 2206 people globally.
- To date, 96,888 confirmed cases of COVID-19 have emerged.
- For details on the real-time prevalence and spread of COVID-19, click here.[1]
Case-fatality rate
- With 8,098 confirmed cases, the case fatality-rate of SARS was 9.6%.[2]
- With 2465 laboratory-confirmed cases, the case fatality-rate of MERS was 34.4%.
- The case fatality-rate of 2019-nCoV in the first 99 patients at a Wuhan hospital (the epicenter of the outbreak) has been found to be 11%.[3]
- In a different study comprising of 138 patients infected with 2019-nCoV, the mortality has been established to be 4.3%.[4]
Age
- Patients of all age groups can develop the disease.
- The median age of patients suffering from COVID-19 has been established to be 59 years.[5]
Race
- Coronavirus infections affect all races.
Gender
- Coronavirus infections affect men and women equally.
- In a recent study, 2019-nCoV has been found to have infected males more than females.[6]
Region
- Majority of the cases of SARS-CoV infection were reported in China before spreading to 29 other countries.[7]
- Majority of the cases of MERS-CoV infection were reported in the Middle East (mainly in the Kingdom of Saudi Arabia) before spreading to 27 other countries.
- Majority of the cases of COVID-19 have been reported in China and the disease has spread to 67 countries (including the United States) so far.[8]
Recent Outbreaks
2019-nCoV
Global
- Majority of the cases of COVID-19 have been reported in China and the disease has spread to 67 countries (including the United States) so far.[8]
Status in the United States
Total Cases | 43 |
---|---|
Total hospitalized | 17 |
Total deaths | 2 |
States reporting cases | 10 |
- These data represent cases detected and tested in the United States through U.S. public health surveillance systems since January 21, 2020. It does not include people who returned to the U.S. via State Department-chartered flights.[11]
- For details on the real-time prevalence and spread of COVID-19 in the United States, click here.
References
- ↑ https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Missing or empty
|title=
(help) - ↑ Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (January 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China". Int. J. Infect. Dis. 91: 264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.
- ↑ Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin (2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". The Lancet. doi:10.1016/S0140-6736(20)30183-5. ISSN 0140-6736.
- ↑ Wang, Dawei; Hu, Bo; Hu, Chang; Zhu, Fangfang; Liu, Xing; Zhang, Jing; Wang, Binbin; Xiang, Hui; Cheng, Zhenshun; Xiong, Yong; Zhao, Yan; Li, Yirong; Wang, Xinghuan; Peng, Zhiyong (2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. ISSN 0098-7484.
- ↑ Li, Qun; Guan, Xuhua; Wu, Peng; Wang, Xiaoye; Zhou, Lei; Tong, Yeqing; Ren, Ruiqi; Leung, Kathy S.M.; Lau, Eric H.Y.; Wong, Jessica Y.; Xing, Xuesen; Xiang, Nijuan; Wu, Yang; Li, Chao; Chen, Qi; Li, Dan; Liu, Tian; Zhao, Jing; Liu, Man; Tu, Wenxiao; Chen, Chuding; Jin, Lianmei; Yang, Rui; Wang, Qi; Zhou, Suhua; Wang, Rui; Liu, Hui; Luo, Yinbo; Liu, Yuan; Shao, Ge; Li, Huan; Tao, Zhongfa; Yang, Yang; Deng, Zhiqiang; Liu, Boxi; Ma, Zhitao; Zhang, Yanping; Shi, Guoqing; Lam, Tommy T.Y.; Wu, Joseph T.; Gao, George F.; Cowling, Benjamin J.; Yang, Bo; Leung, Gabriel M.; Feng, Zijian (2020). "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia". New England Journal of Medicine. doi:10.1056/NEJMoa2001316. ISSN 0028-4793.
- ↑ Li, Qun; Guan, Xuhua; Wu, Peng; Wang, Xiaoye; Zhou, Lei; Tong, Yeqing; Ren, Ruiqi; Leung, Kathy S.M.; Lau, Eric H.Y.; Wong, Jessica Y.; Xing, Xuesen; Xiang, Nijuan; Wu, Yang; Li, Chao; Chen, Qi; Li, Dan; Liu, Tian; Zhao, Jing; Liu, Man; Tu, Wenxiao; Chen, Chuding; Jin, Lianmei; Yang, Rui; Wang, Qi; Zhou, Suhua; Wang, Rui; Liu, Hui; Luo, Yinbo; Liu, Yuan; Shao, Ge; Li, Huan; Tao, Zhongfa; Yang, Yang; Deng, Zhiqiang; Liu, Boxi; Ma, Zhitao; Zhang, Yanping; Shi, Guoqing; Lam, Tommy T.Y.; Wu, Joseph T.; Gao, George F.; Cowling, Benjamin J.; Yang, Bo; Leung, Gabriel M.; Feng, Zijian (2020). "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia". New England Journal of Medicine. doi:10.1056/NEJMoa2001316. ISSN 0028-4793.
- ↑ Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (January 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China". Int. J. Infect. Dis. 91: 264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.
- ↑ 8.0 8.1 https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html. Missing or empty
|title=
(help) - ↑ https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Missing or empty
|title=
(help) - ↑ https://www.cdc.gov/coronavirus/2019-ncov/locations-confirmed-cases.html. Missing or empty
|title=
(help) - ↑ https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html. Missing or empty
|title=
(help)